Ray Dalio's IONS Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 67,706 shares of Ionis Pharmaceuticals, Inc. (IONS) worth $5.36 M, representing 0.02% of the portfolio. First purchased in 2021-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Ray Dalio has maintained this position in IONS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 43,578 shares. Largest reduction occurred in Q3 2022, reducing 9,779 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Ionis Pharmaceuticals (IONS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ionis Pharmaceuticals (IONS) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +24,128 | Add 55.37% | 67,706 | $79.11 |
| Q3 2025 | +43,578 | New Buy | 43,578 | $65.42 |
| Q3 2022 | -9,779 | Sold Out | 0 | $0.00 |
| Q2 2022 | +2,578 | Add 35.80% | 9,779 | $37.02 |
| Q1 2022 | +7,201 | New Buy | 7,201 | $37.08 |
| Q3 2021 | -7,981 | Sold Out | 0 | $0.00 |
| Q2 2021 | +7,981 | New Buy | 7,981 | $39.84 |
Ray Dalio's Ionis Pharmaceuticals Investment FAQs
Ray Dalio first purchased Ionis Pharmaceuticals, Inc. (IONS) in Q2 2021, acquiring 7,981 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Ionis Pharmaceuticals, Inc. (IONS) for 7 quarters since Q2 2021.
Ray Dalio's largest addition to Ionis Pharmaceuticals, Inc. (IONS) was in Q3 2025, adding 43,578 shares worth $2.85 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 67,706 shares of Ionis Pharmaceuticals, Inc. (IONS), valued at approximately $5.36 M.
As of the Q4 2025 filing, Ionis Pharmaceuticals, Inc. (IONS) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Ionis Pharmaceuticals, Inc. (IONS) was 67,706 shares, as reported at the end of Q4 2025.